Thick Fluid Around Glioblastoma Makes Brain Cancer Cells Smaller and More Invasive

Glioblastoma is among the most lethal brain cancers, in part because its cells infiltrate healthy tissue and make complete surgical removal nearly impossible. Cancer research has long focused on chemical signals and tissue stiffness to explain this invasion. A new study suggests a third factor deserves attention: the thickness, or viscosity, of the fluid surrounding the tumor.

Researchers from Chongqing General Hospital and Chongqing University point out that fluid at a glioblastoma's advancing edge is about eight times more viscous than fluid in the dead tissue at its center. As cells move outward, they push through increasing resistance. Studying this has been hard because conventional closed microfluidic devices limit oxygen and nutrient access and add wall friction that confounds results.

To solve this, the team built an open two-layer microfluidic membrane platform with a removable cap to control when migration begins, plus a ring of micropillars that squeezes cells and deforms their nuclei. This setup activates YAP mechanotransduction, a pathway through which cells sense physical force. They cultured glioblastoma cells long term in medium with a viscosity of 7.1 cP, mimicking the invasive periphery. The cells became smaller, more flexible, and better able to pass through narrow openings. Responses varied by cell type, and some changes persisted after the cells left the viscous fluid, indicating lasting adaptation.

The key insight is that viscosity is not merely a barrier. It actively shapes cell behavior and may make tumors more aggressive. This opens possible new strategies, such as targeting mechanosensing pathways like YAP or the physical properties of the tumor microenvironment, and gives researchers a better tool for testing drugs against invasion.

There are important caveats. This is laboratory work using cultured cells on an engineered chip, not animals or patients. The persistence of the changes, the full molecular mechanisms, and whether the findings hold in living brain tissue all remain to be established. No treatment or patient-facing recommendation follows yet, and independent replication will be needed.